Ï㽶ÊÓƵ

Génome Québec invests up to $500,000 to boost Ï㽶ÊÓƵ therapeutics innovation in Quebec

Génome Québec, a private, non-profit organization dedicated to advancing genomics research and innovation in Quebec, is investing up to $500,000 in Ï㽶ÊÓƵ’s D2R Initiative. This investment will advance the commercialization of innovative genomic technologies in Quebec through D2R’s Commercialization Priming funding program.

Category:
Published on: 2 Oct 2024

Join Ï㽶ÊÓƵ Health Centre's next “Medical Genetics Grand Roundsâ€

The founder effect, which is observed in certain regions of Quebec, can increase susceptibility to rare disease. This stems from the fact that these communities were founded by populations that were already related.

Category:
Published on: 26 Sep 2024

D2R awards $7.3 million to Advance Research in Genomic-Based Ï㽶ÊÓƵ Therapeutics

Montreal – September 17, 2024Ìý Ï㽶ÊÓƵ’s D2R initiative is proud to announce the 23 recipients of its inaugural funding programs, Foundational Projects and Research in Motion. With a total investment of $7.3 million, these awards mark a significant milestone in advancing the field of genomic-based Ï㽶ÊÓƵ therapeutics.

Category:
Published on: 17 Sep 2024

A recent article in La Presse, , highlights how Quebec's life sciences sector is experiencing a significant revival with the creation of an Ï㽶ÊÓƵ hub.

Here is a exerpt from the article (translated to english):Ìý

Category:
Published on: 13 Sep 2024

The McGill community, including researchers in genomic medicine and the health sciences, came together in July 2024 to mark the next phase of one of the University’s most rapidly growing disciplines and celebrate the generosity that is making it possible.Ìý

The occasion was the official unveiling of signage for the Victor Phillip Dahdaleh Institute of Genomic Medicine, and on hand were the Institute’s UK-based benefactors, Victor and Mona Dahdaleh, who were recognized for the far-reaching power of their philanthropy.

Category:
Published on: 19 Aug 2024

Discover how lipid are transforming gene therapy in a new article co-authored by Pieter Cullis,ÌýProfessor, Biochemistry and Molecular Biology at The University of British Columbia.

Category:
Published on: 11 Jul 2024

In a press release published by the Global Alliance for Genomics and Health (GA4GH), it was announced that the Victor Phillip Dahdaleh Institute of Genomic Medicine at Ï㽶ÊÓƵ has joined the alliance as a Host Institution. GA4GH is a not-for-profit alliance uniting the international community dedicated to advancing human health through genomic data.

Category:
Published on: 20 Jun 2024

Honour is recognition for a lifetime of leading research

Alan Evans, a researcher at The Neuro, James McGill Professor of Neurology and Neurosurgery and co-director of the Ludmer Centre for Neuroinformatics and Mental Health, has been elected to the Fellowship of the Royal Society, joining a class of scientists that includes a Nobel laureate and a former Chief Medical Advisor to the US President.ÌýÌý

Classified as: Neuro, Alan Evans, MNI, Royal Society, ACAR News
Published on: 17 Jun 2024

Researchers will study how hormones affect brain cancer and the role of neural circuits in social skills

The Paris Brain Institute and the Institut Pasteur have partnered with The Neuro to fund two groundbreaking studies, each receiving more than $440,000. These projects are part of an international collaboration to address future challenges in neuroscience.

Classified as: Neuro, MNI, Justine Cléry, Stefano Stifani, glioblastoma, brain circuits, ACAR News
Published on: 14 Jun 2024

Imagine a world where your unique genetic makeup can be used to tailor your medical care, and where illnesses and disease are treated with pinpoint accuracy.

On June 11, 2024 three McGill professors at the forefront of the genomic revolution discuss in this webcast the opportunities and ethical pitfalls behind genetics, immunotherapy and personalized medicine. They discuss the various ways in which these scientific advances promise to revolutionize how we think about and treat diseases, from diabetes to cancer.

Speakers:Ìý

Category:
Published on: 13 Jun 2024

On June 3, 2024, CQDM, in collaboration with Axelys, Montréal InVivo and Ï㽶ÊÓƵ Québec introduced AReNA, a new Ï㽶ÊÓƵ hub in Quebec. Unveiled at the BIO conference in San Diego, in the presence of the Minister for the Economy, the Minister responsible for the Fight Against Racism, and the Minister responsible for the Laval region, Mr. Christopher Skeete, this initiative seeks to bring together key players in life sciences and aims to propel Quebec to the forefront of innovation in the field of Ï㽶ÊÓƵ therapies.

Category:
Published on: 13 Jun 2024

On June 11, 2024ÌýCQDM announced the creation of theÌýÏ㽶ÊÓƵ Therapy Development and Production Network, which will offer Ï㽶ÊÓƵ therapy biomanufacturing services to academic and industrial researchers.

Category:
Published on: 13 Jun 2024

June 4, 2024 |ÌýThe is designed to support unhoused military Veterans and offers wrap around social support programing, in partnership with Veterans Affairs, to help with their transition to civilian life.ÌýKingston Veterans’ Village features 20 tiny homes, a resource centre, two counsellor offices, recreation spaces, and community gardens.ÌýA recent study by the Max Bell School of Policy Studies at Ï㽶ÊÓƵ estimat

Classified as: Student, homelessness
Category:
Published on: 6 Jun 2024

Date: Thursday 13 June 2024, 11:00-13:00

Category:
Published on: 3 Jun 2024

Date: Tuesday June 11, 2024 from 12-1pm

Location: Online


Imagine a world where your unique genetic makeup can be used to tailor your medical care, and where illnesses and disease are treated with pinpoint accuracy.

Category:
Published on: 3 Jun 2024

Pages

Back to top